Beam Therapeutics Inc. News
Verve Therapeutics Crushed By Clinical Hold
The FDA is taking a cautious approach to gene editing clinical trials in the United States, forcing companies to go overseas for early data generation.
The Next Crispr Gene Editing IPO Could Be Near
Prime Medicine, a third-generation Crispr company, may test the choppy waters of the stock market with an IPO.
Cathie Wood Watch: Ark Buys Into Slumping Software Firm, Sells 3D Printing
Wood's flagship Ark Innovation ETF has sunk 54% so far this year, and is down 73% from its February 2021 peak.
Cathie Wood Watch: This Firm Programs Cells, Using DNA as Code
Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.
Stocks Close Mixed, Nasdaq Snaps Losing Streak
Stocks finish mixed Monday with the Nasdaq turning positive to snap a four-day losing streak.
Stock Market Today: Inflation Fears Pound Tech, Omicron Wave Tests Growth Bets; Bond Yields Hit 1.8%
Wall Street looks set to extend last week's declines, with tech stocks leading to the downside, ahead of a key reading of December inflation, Jerome Powell testimony and the start of the fourth quarter earnings season.
Beam Therapeutics Stock Active After $1.35 Billion Pfizer Drug Development Deal
Boston-based Beam Therapeutics has agreed to a potential $1.35 billion drug development deal with pharma giant Pfizer.
Intellia Therapeutics Leads Gene-Editing Stock Rally
Intellia Therapeutics rises and other gene-editing stocks follow suit.
Moderna, Novavax Make JPMorgan Short Pick List
Moderna and Novavax rank high in JPMorgan survey of biotech short picks.
Bourbon Whiskey -- A Brief History of This All-American Drink
Why not celebrate this Fourth of July by savoring some bourbon, a truly American spirit. Here's a brief history of our national whiskey.
Breaking News
President Biden To Sign Bill Preventing Rail Strike 'Catastrophe' Following Senate Approval
"Working together, we have spared this country a Christmas catastrophe in our grocery stores, in our workplaces, and in our communities," President Biden said
Marvell Stock Slumps On Q3 Earnings Miss, Soft Chip Sector Outlook
"Inventory reductions, in particular at our storage customers, are impacting our near-term results and guidance," said CEO Matt Murphy.
General Mills Tries a New Take on Lucky Charms
The new variant may be even more magically delicious.
Elon Musk's Latest Twitter Move Looks Like an Act of Desperation
Twitter is desperate for revenue. It has a $13 billion debt burden, but hasn’t showed a profit for eight of the last 10 years.